Pena-Burgos EM, Serra del Carpio G, Tapia-Viñe M, Suárez-González J, Buño I, Ortiz-Cruz E, Pozo-Kreilinger JJ. Liposclerosing Myxofibrous Tumor: A Separated Clinical Entity? Diagnostics. 2025; 15(5):536. https://doi.org/10.3390/diagnostics15050536
Abstract: Introduction: Liposclerosing myxofibrous tumors (LSMFTs) have been described as an infrequent and peculiar fibrous dysplasia variant with a predilection for the intertrochanteric femoral region and are not globally considered a distinct tumor. Given their features, they may be confused with a variety of entities. Our aim is to analyze the clinical, radiological, histopathological and molecular features of LSMFTs
Liposclerosing Myxofibrous Tumor A Separated Clinical Entity PAPER 2025
